Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 275

1.

Evaluation of a point-of-care test based on deamidated gliadin peptides for celiac disease screening in a large pediatric population.

Bienvenu F, Besson Duvanel C, Seignovert C, Rouzaire P, Lachaux A, Bienvenu J.

Eur J Gastroenterol Hepatol. 2012 Dec;24(12):1418-23. doi: 10.1097/MEG.0b013e3283582d95.

PMID:
23032795
2.

Diagnostic accuracy of a new point-of-care screening assay for celiac disease.

Benkebil F, Combescure C, Anghel SI, Besson Duvanel C, Schäppi MG.

World J Gastroenterol. 2013 Aug 21;19(31):5111-7. doi: 10.3748/wjg.v19.i31.5111.

3.

Early diagnosis of celiac disease in IgA deficient children: contribution of a point-of-care test.

Bienvenu F, Anghel SI, Besson Duvanel C, Guillemaud J, Garnier L, Renosi F, Lachaux A, Bienvenu J.

BMC Gastroenterol. 2014 Nov 6;14:186. doi: 10.1186/1471-230X-14-186.

4.

Clinical evaluation of the BioPlex 2200 Celiac IgA and IgG Kits - a novel multiplex screen incorporating an integral check for IgA deficiency.

Holding S, Wilson F, Spradbery D.

J Immunol Methods. 2014 Mar;405:29-34. doi: 10.1016/j.jim.2014.01.002. Epub 2014 Jan 12.

PMID:
24424297
5.

Diagnostic efficacy of the ELISA test for the detection of deamidated anti-gliadin peptide antibodies in the diagnosis and monitoring of celiac disease.

Tonutti E, Visentini D, Picierno A, Bizzaro N, Villalta D, Tozzoli R, Kodermaz G, Carroccio A, Iacono G, Teresi S, La Chiusa SM, Brusca I.

J Clin Lab Anal. 2009;23(3):165-71. doi: 10.1002/jcla.20313.

PMID:
19455636
6.

Evaluating diagnostic accuracy of anti-tissue Transglutaminase IgA antibodies as first screening for Celiac Disease in very young children.

Frulio G, Polimeno A, Palmieri D, Fumi M, Auricchio R, Piccolo E, Carandente Giarrusso P.

Clin Chim Acta. 2015 Jun 15;446:237-40. doi: 10.1016/j.cca.2015.04.035. Epub 2015 May 2.

PMID:
25944768
7.

Diagnostic value of anti-deamidated gliadin peptide IgG antibodies for celiac disease in children and IgA-deficient patients.

Mozo L, Gómez J, Escanlar E, Bousoño C, Gutiérrez C.

J Pediatr Gastroenterol Nutr. 2012 Jul;55(1):50-5. doi: 10.1097/MPG.0b013e31824703c7.

PMID:
22197936
8.
9.

Antibody responses to deamidated gliadin peptide show high specificity and parallel antibodies to tissue transglutaminase in developing coeliac disease.

Ankelo M, Kleimola V, Simell S, Simell O, Knip M, Jokisalo E, Tarkia M, Westerlund A, He Q, Viander M, Ilonen J, Hinkkanen AE.

Clin Exp Immunol. 2007 Nov;150(2):285-93. Epub 2007 Sep 4.

10.

Immunoglobulin G antibodies against deamidated-gliadin-peptides outperform anti-endomysium and tissue transglutaminase antibodies in children <2 years age.

Mubarak A, Gmelig-Meyling FH, Wolters VM, Ten Kate FJ, Houwen RH.

APMIS. 2011 Dec;119(12):894-900. doi: 10.1111/j.1600-0463.2011.02817.x. Epub 2011 Sep 22.

PMID:
22085366
11.

Antibodies against synthetic deamidated gliadin peptides as predictors of celiac disease: prospective assessment in an adult population with a high pretest probability of disease.

Niveloni S, Sugai E, Cabanne A, Vazquez H, Argonz J, Smecuol E, Moreno ML, Nachman F, Mazure R, Kogan Z, Gomez JC, Mauriño E, Bai JC.

Clin Chem. 2007 Dec;53(12):2186-92. Epub 2007 Sep 27.

12.

Diagnostic accuracy of coeliac serological tests: a prospective study.

Reeves GE, Squance ML, Duggan AE, Murugasu RR, Wilson RJ, Wong RC, Gibson RA, Steele RH, Pollock WK.

Eur J Gastroenterol Hepatol. 2006 May;18(5):493-501.

PMID:
16607143
13.

Celiac G+ antibody assay for the detection of autoantibodies in celiac disease.

Bansal AK, Lindemann MJ, Ramsperger V, Kumar V.

Ann N Y Acad Sci. 2009 Sep;1173:36-40. doi: 10.1111/j.1749-6632.2009.04848.x.

PMID:
19758129
14.

Accuracy of diagnostic antibody tests for coeliac disease in children: summary of an evidence report.

Giersiepen K, Lelgemann M, Stuhldreher N, Ronfani L, Husby S, Koletzko S, Korponay-Szabó IR; ESPGHAN Working Group on Coeliac Disease Diagnosis.

J Pediatr Gastroenterol Nutr. 2012 Feb;54(2):229-41. doi: 10.1097/MPG.0b013e318216f2e5. Review.

PMID:
22266486
15.

Positive tissue transglutaminase antibodies with negative endomysial antibodies: low rate of celiac disease.

Weiss B, Bujanover Y, Avidan B, Fradkin A, Weintraub I, Shainberg B.

Isr Med Assoc J. 2004 Jan;6(1):9-12.

16.

New developments in serodiagnosis of childhood celiac disease: assay of antibodies against deamidated gliadin.

Prause C, Richter T, Koletzko S, Uhlig HH, Hauer AC, Stern M, Zimmer KP, Laass MW, Probst C, Schlumberger W, Mothes T.

Ann N Y Acad Sci. 2009 Sep;1173:28-35. doi: 10.1111/j.1749-6632.2009.04638.x.

PMID:
19758128
17.

Application of Deamidated Gliadin Antibodies in the Follow-Up of Treated Celiac Disease.

de Chaisemartin L, Meatchi T, Malamut G, Fernani-Oukil F, Hosking F, Rault D, Bellery F, Cellier C, Dragon-Durey MA.

PLoS One. 2015 Aug 31;10(8):e0136745. doi: 10.1371/journal.pone.0136745. eCollection 2015.

18.

Antibodies against deamidated gliadin peptides and tissue transglutaminase for diagnosis of pediatric celiac disease.

Olen O, Gudjónsdóttir AH, Browaldh L, Hessami M, Elvin K, Liedberg AS, Neovius M, Grahnquist L.

J Pediatr Gastroenterol Nutr. 2012 Dec;55(6):695-700. doi: 10.1097/MPG.0b013e3182645c54.

PMID:
22722680
19.

Intestinal biopsy is not always required to diagnose celiac disease: a retrospective analysis of combined antibody tests.

Bürgin-Wolff A, Mauro B, Faruk H.

BMC Gastroenterol. 2013 Jan 23;13:19. doi: 10.1186/1471-230X-13-19.

20.

Supplemental Content

Support Center